The pivotal programs include STEP for semaglutide in weight management (published in The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide in weight management (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)
For Heart Health 2,000-4,000 milligrams per day Enhances heart function and decreases inflammation
Considering the significant health benefits and reduced medical costs from treating obesity, the National Consumers League urges Rhode Islands General Assembly to maintain GLP-1 obesity treatment coverage for Medicaid patients
First 46 hours Pause greasy, spicy, fizzy, and rich foods
Five years later, it partnered with Lilly to develop pramlintide, an amylin analog for the treatment of diabetes